Literature DB >> 28114797

Associations of depression status and hopelessness with blood pressure: a 24-year follow-up study.

Sarah J Roane1, Patrick Pössel1, Amanda M Mitchell1, William W Eaton2.   

Abstract

Hypertension is estimated to cause 12.8% of all deaths worldwide. Both literature and well-supported cognitive models indicate that hopelessness predicts depressive symptoms. This study aimed to test whether high levels of hopelessness are associated with increased blood pressure, as well as whether depression acts as a mediator between hopelessness and blood pressure. Data from the original 24-year longitudinal Baltimore Epidemiologic Catchment Area Study (ECA) were analyzed via linear regression (N = 917; 60.3% female; 62.9% European American; mean age = 42.96 years, SD = 16.94). Hopelessness was found to have a significant direct relationship with systolic blood pressure (SBP, p < .05), but not with diastolic blood pressure (DBP, p > .05); while depression had no significant direct relationship with SBP or with DBP. Overall, findings indicated that hopelessness has a significant relationship with SBP. Limitations and implications are discussed.

Entities:  

Keywords:  Depression; diastolic blood pressure; hopelessness; hypertension; systolic blood pressure

Mesh:

Year:  2017        PMID: 28114797      PMCID: PMC9004700          DOI: 10.1080/13548506.2017.1281977

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  27 in total

1.  Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods       Date:  2008-08

2.  Likert scales, levels of measurement and the "laws" of statistics.

Authors:  Geoff Norman
Journal:  Adv Health Sci Educ Theory Pract       Date:  2010-02-10       Impact factor: 3.853

3.  Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study.

Authors:  S A Everson; G A Kaplan; D E Goldberg; R Salonen; J T Salonen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-08       Impact factor: 8.311

4.  Major depression and cancer: the 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States).

Authors:  J J Gallo; H K Armenian; D E Ford; W W Eaton; A S Khachaturian
Journal:  Cancer Causes Control       Date:  2000-09       Impact factor: 2.506

5.  Population-based study of first onset and chronicity in major depressive disorder.

Authors:  William W Eaton; Huibo Shao; Gerald Nestadt; Hochang Benjamin Lee; Ben Hochang Lee; O Joseph Bienvenu; Peter Zandi
Journal:  Arch Gen Psychiatry       Date:  2008-05

Review 6.  Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis.

Authors:  R de Miranda Azevedo; A M Roest; P W Hoen; P de Jonge
Journal:  Psychol Med       Date:  2014-01-27       Impact factor: 7.723

7.  Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease.

Authors:  J Stamler; J D Neaton; D N Wentworth
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

8.  Hopelessness -- novel facet of the metabolic syndrome in men.

Authors:  Maarit Valtonen; David E Laaksonen; Tommi Tolmunen; Kristiina Nyyssönen; Heimo Viinamäki; Jussi Kauhanen; Leo Niskanen
Journal:  Scand J Public Health       Date:  2008-11       Impact factor: 3.021

Review 9.  Cardiovascular consequences of cortisol excess.

Authors:  Judith A Whitworth; Paula M Williamson; George Mangos; John J Kelly
Journal:  Vasc Health Risk Manag       Date:  2005

10.  Excess risk of chronic physical conditions associated with depression and anxiety.

Authors:  Rituparna Bhattacharya; Chan Shen; Usha Sambamoorthi
Journal:  BMC Psychiatry       Date:  2014-01-16       Impact factor: 3.630

View more
  1 in total

1.  Psychological Distress, Self-Beliefs, and Risk of Cognitive Impairment and Dementia.

Authors:  Angelina R Sutin; Yannick Stephan; Antonio Terracciano
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.